Zylig Lifesciences

Monopoly Based Pharma Franchise

Contact information
Zylig Lifesciences is growing Pharmaceutical Company In India. We deal in monopoly based PCD Pharma Franchise at Low investment. We have more than 700+ products in Injectables, Infusions, Capsules, Tablets, Nutraceuticals, Ayurvedic products, And Sanitizers. Our products are W.H.O and GMP Certified.

Contact information

Zylig Lifesciences
Plot No 1, Near Bharat Petrol Pump, Nanhera Road, Kuldeep Nagar
133001 Ambala Cantt
India
Directions

Contact person
Zylig Lifesciences - PCD Pharma Franchise Company/ PCD Pharma Companies in Ambala

Images & Videos

Websites

Social Media

Submit a review

Your message to Zylig Lifesciences

Please complete the field highlighted in red.
Please complete the field highlighted in red.
Invalid email address
* required fields
Invalid characters. Only numbers and space characters are possible.

I accept the privacy policy.

Profile active since 04/12/2021  |  Last update: 04/12/2021   |  Report profile

More transparency and security while looking for competent professionals

Authentic customer opinions
Take advantage of other customers' experiences: ProvenExpert's authenticated customer reviews can help you choose the right product or service.
Effective customer feedback
ProvenExpert allows the entire service spectrum of a company (e.g. customer service, consulting) to be reviewed. This way you get a detailed overview of your service quality in all areas.
Independent reviews
ProvenExpert is free, independent, and neutral. Customers make reviews of their own accord — their opinions are not for sale. And the content of reviews cannot be influenced by money or by any other means.

A good reputation is the world's
best form of advertising!

85% of all consumers trust online reviews just as much as they do personal recommendations.

Let ProvenExpert give your business a boost with the best advertising in the world: the opinions of satisfied customers.
Review Guidelines  |  Quality Assurance  |  Privacy Policy  |  Legal Notice  © 2011 - 2024 Expert Systems GmbH